| 标题 |
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:J Clin Oncol 作者:Qin S, Bi F, Gu S, Bai Y, Chen Z, Wang Z, Ying J, Lu Y, Meng Z, Pan H, Yang P, Zhang H, Chen X, Xu A, Cui C, Zhu B, Wu J, Xin X, Wang J, Shan J, Chen J, Zheng Z, Xu L, Wen X, You Z, Ren Z, Liu X, Qiu M, Wu L, Chen F 出版日期:2021-06-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)